Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta

Journal of Hepatology（2023）

引用 2|浏览26

暂无评分

摘要

查看译文

关键词

peginterferon alfa,ritonavir,double-blind placebo-controlled,d-livr,lonafarnib-boosted

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要